Dentists Keep Prescribing Clindamycin Despite ‘Black Box’ Label, C Diff Risk

Dentists Keep Prescribing Clindamycin Despite ‘Black Box’ Label, C Diff Risk CIDRAP takes a deeper look at the antibiotic's health effects. Also in the news: The FDA has approved milsaperidone to treat schizophrenia and bipolar disorder; Bayer sues Johnson & Johnson; Mounjaro may reduce alcohol intake; and more. https://kffhealthnews.org/morning-breakout/dentists-keep-prescribing-clindamycin-despite-black-box-label-c-diff-risk/